Starpharma Holdings Ltd has released a press release.
Starpharma receives $7.7M R&D tax incentive refund
Filed with ASX ·
6ix hasn’t read this filing yet.
Starpharma Holdings Limited on 6ix
Earlier from Starpharma
- VIRALEZE successfully launched in Vietnam
- Starpharma signs DEP Research Agreement with US Biopharma Co
- VIRALEZE distribution agreement and launch in Vietnam
- VIRALEZE registered in Vietnam with launch this week
- AGM Chairman address and CEO presentation
Later from Starpharma
- Starpharma - Quarterly Cashflow and Activities Report
- VIRALEZE sales and distribution in Saudi Arabia and GCC
- Interim Report and Half-Year Financial Results
- SPL7013 in VIRALEZE virucidal against Omicron
- Application for quotation of securities - SPL
Follow Starpharma into a list and get an email when it puts out news.
Follow Starpharma